Maternal COVID-19 exposure and placental characteristics.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 30 06 2023
accepted: 05 04 2024
medline: 23 5 2024
pubmed: 23 5 2024
entrez: 23 5 2024
Statut: epublish

Résumé

The impact of COVID-19 on the placenta is poorly described, particularly among minority women. This is a retrospective case-control study. Micro- and macroscopic placental pathologic findings were compared for 15 COVID-19 positive and 36 negative mothers. Cases and controls were frequency matched on gestational age, race, maternal comorbidities, and delivery type. Data from the electronic medical record were supplemented with independent review of microscopic slides. Placentas from cases and controls were similar except the median distance from the site of the cord insertion to the nearest disk margin was statistically significantly shorter among placentas from COVID-19 positive cases (3.5 versus 6.0 cm, p = 0.006). Case status was not associated with an increased risk of placental pathologies. There are few pathologic differences between placentas of COVID-19 positive and negative mothers. Additional studies are needed to investigate the role of timing of infection.

Identifiants

pubmed: 38781150
doi: 10.1371/journal.pone.0302682
pii: PONE-D-23-19385
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0302682

Informations de copyright

Copyright: © 2024 Allo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Ghassan Allo (G)

Department of Pathology, Henry Ford Hospital, Detroit, MI, United States of America.
Department of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, East Lansing, MI, United States of America.

Alexandra R Sitarik (AR)

Department of Public Health Sciences, Henry Ford Health, Detroit, MI, United States of America.

Ashley Redding (A)

Department of Public Health Sciences, Henry Ford Health, Detroit, MI, United States of America.

Chad M Coleman (CM)

Department of Public Health Sciences, Henry Ford Health, Detroit, MI, United States of America.

Andrea E Cassidy-Bushrow (AE)

Department of Public Health Sciences, Henry Ford Health, Detroit, MI, United States of America.

Arthur Gaba (A)

Department of Pathology, Henry Ford Hospital, Detroit, MI, United States of America.

Jennifer K Straughen (JK)

Department of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, East Lansing, MI, United States of America.
Department of Public Health Sciences, Henry Ford Health, Detroit, MI, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH